Nymox Pharmaceutical
NYMX
#10184
Rank
HK$0.14 B
Marketcap
Country
HK$1.56
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -HK$0.47

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -HK$0.47. In 2022 the company made an earnings per share (EPS) of -HK$0.63 an increase over its 2021 EPS that were of -HK$1.17.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$0.47-24.72%
2022-HK$0.63-46.67%
2021-HK$1.17-11.76%
2020-HK$1.33-15%
2019-HK$1.565.26%
2018-HK$1.48-26.92%
2017-HK$2.03-7.14%
2016-HK$2.19-40.43%
2015-HK$3.67291.67%
2014-HK$0.94-7.69%
2013-HK$1.02-43.48%
2012-HK$1.80-25.81%
2011-HK$2.4255%
2010-HK$1.5625%
2009-HK$1.250.08%
2008-HK$1.25-11.12%
2007-HK$1.41-0.16%
2006-HK$1.4128.59%
2005-HK$1.09-12.49%
2004-HK$1.25-16.05%
2003-HK$1.4919.07%
2002-HK$1.2514.45%
2001-HK$1.09-22.16%
2000-HK$1.405.64%
1999-HK$1.33-34.59%
1998-HK$2.03-3.6%
1997-HK$2.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-17,499.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.44-2,966.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.95-13,528.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30-34,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$67.50-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA